Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ayaka Sugiyama"'
Autor:
Takuya Yoshida, Masayuki Tsujimoto, Sachiyo Kawakami, Haruno Fujioka, Yuko Irie, Saki Nakatani, Ayako Iso, Ayaka Sugiyama, Mizuho Miyake, Kazumi Hirato, Rie Tanaka, Tomoko Oda, Taku Furukubo, Satoshi Izumi, Tomoyuki Yamakawa, Tetsuya Minegaki, Kohshi Nishiguchi
Publikováno v:
Renal Replacement Therapy, Vol 8, Iss 1, Pp 1-8 (2022)
Abstract Background Chronic kidney disease (CKD) is frequently associated with renal anemia. Erythropoiesis-stimulating agent-hyporesponsive anemia is often caused by iron deficiency in patients with CKD. We hypothesized that high accumulation of ind
Externí odkaz:
https://doaj.org/article/a7fa5cb3224f46779ee1db71d5a5db83
Autor:
Ikuhiko Nakase, Natsumi Ueno, Mie Matsuzawa, Kosuke Noguchi, Mami Hirano, Mika Omura, Tomoya Takenaka, Ayaka Sugiyama, Nahoko Bailey Kobayashi, Takuya Hashimoto, Tomoka Takatani‐Nakase, Eiji Yuba, Ikuo Fujii, Shiroh Futaki, Tetsuhiko Yoshida
Publikováno v:
FEBS Open Bio, Vol 11, Iss 3, Pp 753-767 (2021)
Exosomes (extracellular vesicles/EVs) participate in cell–cell communication and contain bioactive molecules, such as microRNAs. However, the detailed characteristics of secreted EVs produced by cells grown under low pH conditions are still unknown
Externí odkaz:
https://doaj.org/article/1f9a5ce9a4174dfbad69440f0723d0c6
Autor:
Shiroh Futaki, Mami Hirano, Ikuhiko Nakase, Kosuke Noguchi, Mika Omura, Nahoko Bailey Kobayashi, Natsumi Ueno, Tomoka Takatani-Nakase, Yoshida Tetsuhiko, Ikuo Fujii, Takuya Hashimoto, Eiji Yuba, Tomoya Takenaka, Ayaka Sugiyama, Mie Matsuzawa
Publikováno v:
FEBS Open Bio
FEBS Open Bio, Vol 11, Iss 3, Pp 753-767 (2021)
FEBS Open Bio, Vol 11, Iss 3, Pp 753-767 (2021)
Exosomes (extracellular vesicles/EVs) participate in cell–cell communication and contain bioactive molecules, such as microRNAs. However, the detailed characteristics of secreted EVs produced by cells grown under low pH conditions are still unknown
Autor:
Masaya Hagiwara, Ikuhiko Nakase, Ayaka Sugiyama, Tomoya Takenaka, Tomoka Takatani-Nakase, Susumu Kobayashi, Miku Katayama, Ikuo Fujii
Publikováno v:
Anticancer Research. 37
Background/aim Gefitinib is a tyrosine kinase inhibitor of epidermal growth factor receptor (EGFR) and has been approved for the treatment of non-small cell lung cancers (NSCLCs) with EGFR mutations. Here we demonstrated that gefitinib induced a sign
Autor:
Tomoya, Takenaka, Miku, Katayama, Ayaka, Sugiyama, Masaya, Hagiwara, Ikuo, Fujii, Tomoka, Takatani-Nakase, Susumu S, Kobayashi, Ikuhiko, Nakase
Publikováno v:
Anticancer research. 37(9)
Gefitinib is a tyrosine kinase inhibitor of epidermal growth factor receptor (EGFR) and has been approved for the treatment of non-small cell lung cancers (NSCLCs) with EGFR mutations. Here we demonstrated that gefitinib induced a significantly enhan
Autor:
Ayaka, SUGIYAMA, Hiromichi, TOMODA
Publikováno v:
學苑 = GAKUEN. 801:56-62
This report clarifies the types and features of a super-high-rise apartment building, 'Tokyo Times Tower', built as part of a development in the area of Akihabara station, and estimates its value as a well-designed 'product' for sale. Its characteris